Retatrutide fact check: Has a man died after taking the unapproved weight loss jab?
Abstract
Retatrutide fact check: Has a man died after taking the unapproved weight loss jab? Elisabeth MahaseThe death of a man taking the unapproved next generation GLP-1 weight loss drug retatrutide made headlines in the national press last week.However, the situation may be less clear cut than the articles suggest.The reports were based on data recorded on the UK drug regulator's adverse events reporting system, the Yellow Card scheme..
Fields of Study & Subjects
Pharmacology and Obesity Treatment
Bariatric Surgery and Outcomes
Forensic Toxicology and Drug Analysis
Publication details
- Journal / source
- BMJ
- Publisher
- BMJ
- Volume
- 394
- Pages
- e100245–e100245
- Publication date
- 9 July 2026
- Language
- EN